In the first quarter of 2023, Hood River Capital Management LLC increased its stake in Lantheus Holdings, Inc. by 4.0%, according to recent disclosure with the U.S. Securities and Exchange Commission (SEC). The investment firm now owns 1,633,626 shares of the medical equipment provider’s stock, acquiring an additional 62,827 shares during this period. With this increase, Lantheus represents about 4.4% of Hood River Capital Management LLC’s holdings, making it their largest holding. This stake is valued at $134,872,000 as of their most recent filing with the SEC.
Lantheus (NASDAQ:LNTH) recently announced its quarterly earnings data on August 3rd, 2023. The company reported earnings per share (EPS) of $1.40 for the quarter, surpassing analysts’ consensus estimates of $1.23 by $0.17. During this period, Lantheus generated revenue of $321.70 million compared to analyst estimates of $306.48 million.
The company’s net margin stood at 2.97%, showcasing its ability to generate profit from its operations despite any challenges faced in the industry. In addition, Lantheus exhibited a strong return on equity of 67.18%, demonstrating efficient utilization of shareholders’ investments.
Sell-side analysts predict that Lantheus Holdings, Inc will post an EPS of 5.19 for the current fiscal year.
This significant boost in Hood River Capital Management LLC’s stake in Lantheus Holdings indicates their confidence in the company’s future prospects and highlights their belief in its growth potential within the medical equipment sector.
Investors should carefully analyze such developments and consider them alongside other relevant factors before making any investment decisions regarding Lantheus or any other companies within this industry.
Please note that this article references information available as of September 10th, 2023, and market conditions or company circumstances may have changed since then.
[bs_slider_forecast ticker=”TFC”]
Lantheus Holdings, Inc. Garners Interest from Investors and Analysts
Lantheus Holdings, Inc. has been generating interest among large investors recently, with several of them either increasing their stakes in the company or reducing them. Fairfield Bush & CO., for instance, acquired a new position in Lantheus during the first quarter worth $177,000, while Raymond James & Associates purchased a new stake valued at approximately $856,000 during the same period.
Bank of New York Mellon Corp also raised its position in shares of Lantheus by 2.7% in the first quarter. The institution now holds 629,033 shares of the medical equipment provider’s stock, which amounts to a value of $34,791,000 after acquiring an additional 16,422 shares.
Additionally, American Century Companies Inc. increased its position in shares of Lantheus by 14.4% in the first quarter, bringing its total holdings to 19,235 shares valued at $1,064,000 after buying an extra 2,427 shares. Finally, HighTower Advisors LLC obtained a new stake worth approximately $354,000 during the first quarter.
It is worth noting that institutional investors and hedge funds currently own around 99.06% of Lantheus’ stock.
The stock has garnered attention from equities research analysts as well. TheStreet upgraded its rating on Lantheus from a “c” to a “b-” in a research report on August 9th. In addition to this positive evaluation from TheStreet analyst team members at StockNews.com have given Lantheus a “buy” rating.
Based on data from Bloomberg cited by various analysts covering this stock it appears that six analysts have rated Lantheus as “Buy.” Overall consensus indicates that shareholders can expect strong performance. Furthermore , these analysts have set an average price target for the stock at $121.83.Investors are advised to monitor closely these estimates provided and reconcile any deviation observed.
Turning to recent developments within the company, President Paul Blanchfield sold 1,500 shares of the stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $65.19, resulting in a total value of $97,785.00. Following this transaction, Blanchfield now holds 90,475 shares of the company’s stock worth approximately $5,898,065.25.
The sale was disclosed in a legal filing with the U.S. Securities and Exchange Commission (SEC), which is available for public viewing at the SEC’s official website.
Another insider activity involved Chief Accounting Officer Andrea Sabens who sold 1,752 shares of Lantheus stock on Wednesday, July 19th. The shares were sold at an average price of $90.87 per share resulting in a total value of $159,204.24 .Following this transaction ,Sabens now directly owns 59,767 shares valued at $5,431.,027.29 according to information released regarding this matter.
Overall ,company insiders have sold a total of 19,315 shares valued at $1,353,773 over the last 90 days.As per regulatory requirements ,public companies are obliged to file insider trading activities with the SEC.It is important for shareholders to evaluate these activities as part of their due diligence process while contemplating future investment decisions.Insider trading can influence investor sentiment either positively or negatively depending upon prevailing market sentiment..
Shares of LNTH opened at $66.40 on Friday.The figures reflect mixed sentiments which could emanate from either reduction or increase in traders’ interest It may also be dependent on general market outlook.
Lantheus Holdings appears favorable from its financial ratios that show balance sheet strength as reflected by its current ratio and quick ratio standing at 4.88 and 4.55 respectively .
In addition data shows that Lantheus has a 12 month low of $47.46 and a 12 month high of $100.85 .The trend so far indicates that market participants have been vircous in nature ,high value traders could use this volatility to their advantage.
This holds significance in view with the data illustrating that Lantheus recorded a 50-day moving average price of $75.80 as well as a 200-day moving average price of $82.01.Needless to emphasize, adhering to strategies that mitigate risks is key,as these price changes demonstrate volatility.Should these prices continue their fluctuating trend , investors should prepare for potential fluctuations over future periods..
With a market capitalization valued at approximately $4.54 billion, Lantheus Holdings has attracted significant interest from investors and analysts alike.It is observed that the company trades at a P/E ratio of 161.95 which speaks volumes concerning investor expectations.
Additionally, the company’s beta reveals a figure of 0.68 which indicates its sensitivity in responding to market movements relative to the benchmark rate..In comparison,beta readings below/above one indicate that movement do not /do disproportionately match movements within the benchmark index
Overall,Lantheus Holdings’ recent activities, both on the part of investors and insiders, suggest an
